INTRODUCTION
Coagulase-negative staphylococci (CoNS) are a hard-to-treat group of microorganisms in relation to implanted foreign materials, due to a high rate of methicillin resistance and biofilm formation [1] . In recent years, the incidence of infections with CoNS has increased [2, 3] . Periprosthetic joint infection (PJI) is a devastating complication after hip and knee arthroplasty that occurs in 1%-2% of patients [4] . When infection persists despite debridement procedures or when infection is diagnosed more than 3 mo postoperatively, it is considered a chronic infection [5] . In case of chronic PJI, removal of the prosthesis is usually indicated [6] . Two-stage revision arthroplasty with the use of an antibiotic-loaded spacer is the gold standard treatment in case of persistent or chronic infection [7, 8] .
The type of spacer used during two-stage revision does not influence the infection eradication rate [9, 10] . In contrast, characteristics of the causative microorganism do influence the chance of infection eradication after two-stage revision [11] . Resistance to commonly prescribed antibiotics is an increasing problem as well [11] . Bacteria such as CoNS can form a biofilm on the prosthesis that prevents elimination by host defences and antimicrobial therapy [1, 12] . In orthopaedic revision arthroplasty, the rate of resistance to antibiotics by CoNS is increasing [13] . The effects of infection exclusively by CoNS on the outcome after two-stage revision arthroplasty have not yet been described. The objective of this study was to evaluate infection eradication rate after two-stage revision arthroplasty of the hip and knee in patients with CoNS PJI.
MATERIALS AND METHODS

Patients
We used the STROBE cohort checklist when writing our report [14] . This study was approved by the local medical ethics committee. After approval, we retrospectively reviewed the records of all patients who had two-stage revision arthroplasty of the hip or knee in our hospital between 2003 and 2016. We included all patients with CoNS PJI of the hip or knee in the study. Exclusion criteria were monomicrobial infection with bacteria other than CoNS and patients receiving one-stage revision. Patients with polymicrobial infection, in whom CoNS was one of the infecting organisms, were included in the study. In all patients, diagnosis of infection was affirmed according to the Musculoskeletal Infection Society criteria. Joint aspirations were routinely performed preoperatively and were positive in all patients.
First-stage surgery
During first-stage surgery, we removed the infected prosthesis including all bone cement (when present). Multiple tissue samples were taken for culture, after which we administered cefuroxime antibiotic prophylaxis. We did not perform sonication of the removed prosthesis. After meticulous debridement, we implanted an antibioticloaded interval spacer with gentamicin and vancomycin. In patients with an infected total hip arthroplasty, we used either a functional articulating spacer or a prefabricated cement spacer ( Figure 1A and B) [10] . Functional articulating spacers consist of (parts of) regularly used hip arthroplasty components combined with antibiotic-impregnated cement. Prefabricated cement spacers are commercially available in different head sizes and two different lengths. In patients with infected total knee arthroplasty we used either static spacers or dynamic spacers ( Figure 1C and D) [15] . Static spacers are blocks of antibiotic-loaded cement that are moulded by hand intra-operatively. Patients were not allowed to bear weight on the static spacer and performing range of motion exercises was not possible. The dynamic spacers were either prefabricated cement blocks, or cement moulded by hand in the shape of a knee prosthesis.
We treated patients with antibiotics according to the recommendations as published by Zimmerli et al [4] . Patients received intravenous antibiotics for at least 2 wk based on the antibiogram of the cultured bacteria. Whenever possible, after 2 wk, we switched antibiotics to an oral substitute for an additional 4-wk minimum. The exact antibiotic treatment was determined in close consultation with a microbiologist and an infectious disease specialist. At 2 wk before the second-stage procedure, we discontinued antibiotics to achieve a 2-wk antibiotic free interval.
Second-stage surgery
During second-stage surgery, we extracted the antibiotic-loaded spacer. Again, we took multiple tissue samples for culture, after which we administered antibiotic prophylaxis. We adjusted the postoperative antibiotic prophylaxis for the antibiogram of the bacteria cultured after the first-stage procedure. We performed another thorough debridement, after which we implanted a revision prosthesis. Postoperatively, patients received intravenous cefuroxime until culture results were available after 2 wk. When culture results were negative, we ceased antibiotics and patients were discharged. In case cultures were still positive, we continued antibiotics for a total of 12 wk.
We retrieved general patient characteristics, preoperative and postoperative laboratory results, complications during treatment, and final outcomes from patients' records. Primary outcome was infection eradication after second-stage procedure, which was defined as the absence of clinical, radiological, or laboratory signs of infection at the latest follow-up, with a minimum of 1 year after second-stage surgery. Secondary outcomes were complications registered during the spacer period and at final follow-up.
Statistical analyses
Failure of treatment was defined as persistent or repeated infection after second-stage procedure, making it necessary to perform another revision, resection arthroplasty, arthrodesis, or amputation of the limb or use of suppressive antibiotics at final followup [16] . We used descriptive statistics, mean, and range to represent the demographics of the patients. Excel and SPSS software were used to perform calculations and statistical analyses. We analysed patients with two-stage revision of hip or knee as one group, and divided them into groups according to the joint treated and the interval spacer used.
RESULTS
Patient characteristics and general outcomes
Between 2003 and 2016 we treated 44 patients with CoNS PJI of a total hip or total knee prosthesis with two-stage revision arthroplasty using an antibiotic-loaded interval spacer. General patient characteristics can be found in Table 1 . Polymicrobial infection was present in six patients. CoNS were sensitive to flucloxacillin or clindamycin in 19 patients. Due to antibiotic resistance to flucloxacillin and clindamycin, we treated 23 patients with vancomycin. We treated 2 patients with linezolid for 4 wk.
Laboratory results showed a mean C-reactive protein (CRP) level of 58 mg/L (range, 2-195) before first-stage surgery. During the spacer interval, the CRP gradually decreased to a mean 17 mg/L (range, 2-186) before second-stage surgery. At final follow-up, the CRP normalised at a mean 8 mg/L (range, 1-28). The leukocyte count remained within normal limits before first-and second-stage surgery and at final follow-up. At the time of final follow-up, three patients had died due to reasons unrelated to treatment. The mean follow-up period was 37 mo (range, 12-119 mo; median 31 mo). Recurrent infection was present in 11 patients (7 hips and 4 knees), of whom 4 had persistent infection with CoNS; the others had re-infection with other bacteria. In addition to the patients with persistent infection, we considered 2 more patients failure of treatment.
Two-stage revision total hip arthroplasty
We treated 29 patients with two-stage revision arthroplasty of an infected total hip prosthesis, for which we used 8 functional articulating spacers and 21 prefabricated spacers ( Table 1) . Polymicrobial infection was present in four patients. Additional causative microorganisms were Propionibacterum acnes in one patient, Pseudomonas aeruginosa in one patient, P. aeruginosa and Enterococcus faecalis in one patient, and haemolytic Streptococci group C in one patient. The other 25 patients had monomicrobial infection with CoNS.
The spacer interval was complicated by dislocation of the spacer in 4 of 21 patients with a prefabricated spacer, and in 1 of 8 patients with a functional articulating spacer. We performed spacer revision because of dislocation in two patients with a prefabricated spacer. Closed reduction was performed in the other two patients with a prefabricated spacer and the patient with a functional articulating spacer. Because of persistent wound effusion, we performed spacer revision within 2 wk after first-stage surgery in four patients with a prefabricated spacer. No spacer exchanges were performed after more than 2 wk.
Second-stage surgery was performed at a median of 8 wk (range, 2-15 wk) after the first-stage procedure. During revision surgery, an uncemented modular femoral revision stem was used in 17 patients and a dual mobility cup was used in 8 patients. All other components used were primary cemented or uncemented stems and cups (head diameter, 32 mm). Postoperatively, 12 patients received antibiotic treatment during the first 2 wk until culture results were negative. Four patients received antibiotic treatment for 6 wk, five patients received antibiotics for 12 wk, and one patient received antibiotics for 26 wk. Patients who had resection arthroplasty of the hip received antibiotics during 6 wk in four cases and during 12 wk in the other patient. Two patients received lifelong suppressive antibiotic therapy: The first due to persistent CoNS infection and the latter due to re-infection with another bacteria.
At final follow-up, we treated 22 patients successfully and considered 7 patients as failures after a mean follow-up of 42 mo (range, 12-119; median, 31 mo). Of the seven patients considered failure of treatment, six were treated with a prefabricated spacer. Due to persistent infection, we eventually accepted a Girdlestone situation in five patients. Two patients received lifelong suppressive antibiotics.
Two-stage revision total knee arthroplasty
We treated 15 patients with two-stage revision arthroplasty of an infected knee prosthesis, using 4 static and 11 dynamic spacers (Table 1) . Polymicrobial infection was present in two patients. The additional causative microorganisms were E. cloacae in one patient and E. faecalis in one patient. The other 13 patients had a monomicrobial infection with CoNS. Spacer interval was complicated by spacer exchange because of persistent wound effusion in two patients with a static spacer. In one patient with a dynamic spacer, a quadriceps tendon rupture occurred peroperatively. Second-stage surgery was performed at a median of 8 wk (range, 4-27 wk) after the first-stage procedure. During second-stage surgery, a hinged type prosthesis was implanted in 11 patients, a constrained prosthesis in 2 patients, and a primary prosthesis in 2 patients. All knee prostheses were cemented. Postoperatively, eight patients received antibiotic treatment during the first 2 wk until culture results were negative. Two patients received antibiotic treatment for 6 wk, two received antibiotics for 12 wk, and one received antibiotics for 26 wk. Two patients received lifelong suppressive antibiotic therapy, both due to persistent CoNS infection.
At final follow-up, we treated nine patients successfully and considered six patients as failures after a mean follow-up of 28 mo (range, 12-59; median 31 mo). Due to persistent infection of the knee, two patients treated with a static spacer underwent further surgical procedures. We performed a second two-stage revision procedure, which eradicated the infection in one patient and an arthrodesis of the knee in the other patient. Two patients treated with a dynamic spacer received lifelong suppressive antibiotics. We performed an above the knee amputation because of persistent pain in one patient, who was treated with a static spacer and arthrodesis of the knee because of insufficiency of the extension mechanism in one patient who was treated with a dynamic spacer. The latter two patients had no demonstrable infection during second-stage revision, but were considered to have failed treatment.
DISCUSSION
This study retrospectively evaluated the infection eradication rate after two-stage revision arthroplasty with the use of an antibiotic-loaded interval spacer of PJI of the hip and knee caused by CoNS. At final follow-up, infection was eradicated in 33 of 44 cases; however we considered 2 more cases as failure of treatment. Poor rates of infection eradication have been reported in cases with polymicrobial infection of the hip or knee [17] . In our series of six patients with polymicrobial infection, one patient failed treatment. Existence of polymicrobial infection did not seem to influence chance of infection eradication negatively; however, the number of polymicrobial infections was too small to draw definite conclusions.
The infection eradication rate was comparable for two-stage revision of the hip (22 of 29) and the knee (11 of 15). The incidence of obesity (body mass index over 30) was higher in the knee group compared to the hip group (8 of 29 vs 9 of 15 patients). Obesity is a known risk factor for PJI [18] [19] [20] . In this series of patients, obesity was not related to a higher risk of persistent infection after two-stage revision arthroplasty of the hip or knee. Recurrence of infection after two-stage revision arthroplasty was also not related to gender, age, smoking status, ASA-classification, or time interval between the first-and second-stage procedure. Functional articulating spacers of the hip and dynamic spacers of the knee seem to lead to lower risk of failure; however the sample size of our study was too small to draw definite conclusions.
One-third of patients (10 of 29 patients) in the group of two-stage revisions of the hip received a primary hip prosthesis due to a proximal femoral fracture. In the other patients, the primary procedure was performed due to osteoarthritis of the hip. In the Netherlands, annually 4% of total hip arthroplasties are implanted because of a femoral neck fracture [21] . This suggests that the risk of infection is higher in patients receiving total hip arthroplasty after a femoral neck fracture. Physicians need to be aware of the increased risk of infection when providing information about hip arthroplasty to patients with hip fractures. Efforts should be made to optimally prepare the patient preoperatively. Treatment of comorbidities causing trauma, the timing and duration of surgery, perioperative antibiotic prophylaxis, and soft tissue management may all influence the chance of periprosthetic infection after total hip prosthesis for a proximal femur fracture. Infection eradication rate after two-stage revision hip arthroplasty was similar in trauma and elective patients (7 of 10 patients vs 14 of 19 patients, respectively, without infection at follow-up).
A limitation of this study is reflected by the retrospective design. The number of patients included in this study was relatively low, which was caused by the scarcity of PJI requiring two-stage revision and the fact that in this study we only focused on CoNS infections. Treatment of patients treated before 2007 was more heterogeneous compared to patients treated after 2007 due to the implementation of stricter perioperative protocols concerning treatment of infected prostheses.
Current literature lacks high-quality studies determining optimal treatment strategy in case of specific causative microorganisms such as CoNS in PJI of the hip and knee. As prospective studies of PJIs are hard to perform due to the scarcity of prosthetic infections, a retrospective multicentre study combining groups of patients to achieve a greater number of patients with CoNS PJI can provide more evidence on how to treat this specific infection. Orthopaedic surgeons should consider treating their patients with a functional articulating spacer of the hip or a dynamic spacer of the knee, as these may improve infection eradication rate. Whether or not functional outcome after two-stage revision with a functional articulating spacer of the hip or a dynamic spacer of the knee is improved compared to their more static counterparts has yet to be studied.
Due to biofilm formation CoNS can be a difficult to treat organism in PJI. The results of this study show that infection eradication rate comparable to that of other causative pathogens may be achieved following two-stage revision arthroplasty of the hip and knee [22] [23] [24] .
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